Sun Pharma receives DCGI approval to launch generic semaglutide injection, Noveltreat, for weight management in India.

Sun Pharmaceutical Industries has received approval from the Drugs Controller General of India (DCGI) to manufacture and ...

India's top drug maker Sun Pharmaceutical Industries has announced today the launch of a generic version of semaglutide, the ...

Danish pharma major Novo Nordisk on Friday launched its blockbuster type 2 diabetes treatment injection Ozempic, globally popular for its weight-loss benefits. Ozempic is now available in India as ...

Sun Pharmaceutical Industries on Friday said it has received approval from the national drug regulator to sell a generic ...